Sanofi, a prominent biopharma company, is on a mission to revolutionize its operations through the power of artificial intelligence (AI). With the goal of becoming the first biopharma company powered by AI at scale, Sanofi is utilizing this technology to accelerate drug discovery, improve clinical trial design, and enhance the manufacturing and supply of crucial medicines and vaccines. Through their partnership with Bluecrux and their digital supply chain twin technology, Axon, Sanofi is paving the way as an innovative leader in the pharmaceutical industry.
The implementation of AI across various domains of the business is shaping Sanofi’s supply chain strategy. By leveraging AI technology, the company aims to deliver “miracles of science to patients” by improving operational efficiency and redirecting savings towards research and development. Bluecrux’s Axon plays a critical role in Sanofi’s digital supply chain transformation. Acting as a digital twin, Axon integrates and harmonizes all of Sanofi’s data systems into a single, comprehensive value chain model. Leif Skibsted Jakobsen, the Head of Digital Supply Chain at Sanofi, emphasizes the significance of this technology, stating that it has already helped identify opportunities to improve inventory and process cycle times, ultimately benefiting patients.
Valerie Vandenbroucke, the VP for Axon Technology at Bluecrux, recognizes the transformative power of Axon in supporting Sanofi’s vision of creating an end-to-end-connected, data-driven, and digitally accelerated supply chain. While the use of the technology is already revolutionizing Sanofi’s operations, Vandenbroucke believes that this is just the beginning, with many more breakthroughs on the horizon.
To further delve into the transformative power of AI in supply chain management, Sanofi and Bluecrux will be hosting a special session at the upcoming Gartner Supply Chain Symposium EMEA conference in Barcelona. During this session, Valérie Vandenbroucke and Sanofi’s Leif Skibsted Jakobsen will present insights into how AI has been harnessed to meet and exceed Sanofi’s business objectives. Attendees will gain valuable information on how Sanofi translated its vision into a practical roadmap and how AI can catalyze true transformation in supply chain management, enabling companies to become end-to-end-connected, data-driven, and digitally accelerated.
Sanofi, as an innovative global healthcare company, is dedicated to improving people’s lives through the pursuit of scientific breakthroughs. Their commitment to sustainability and social responsibility further underscores their mission. Bluecrux, founded in 2011, specializes in value chain technology and consulting, helping global companies improve their supply chain operations through their innovative technologies, Binocs and Axon.
As Sanofi continues to harness the power of AI, their partnership with Bluecrux and the utilization of Axon will undoubtedly propel their supply chain capabilities to new heights. With a focus on delivering groundbreaking treatments and life-saving vaccines, Sanofi is at the forefront of utilizing AI to achieve its ambitious goals. The journey has just begun, and there are bound to be many more exciting breakthroughs on the horizon.
Use the share button below if you liked it.